Cigna raised 2026 outlook and Cigna Group stock sits 6.37 percent below its high

Published on 10/14/2026 at 10:50 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Market value is USD 74.7 billion on October 13, 2026. Cigna Group stock costs EUR 253.00 on October 14, 2026 versus Xetra close EUR 252.70.

Guidance and upcoming reporting

Full-year adjusted earnings per share guidance reached at least USD 30.45 on July 30, 2026.
Fiscal 2025 revenue reached USD 274.9 billion, up 11.2 percent year over year.
Cigna Group stock trades at EUR 253.00 at 10:39 a.m. CEST at Lang & Schwarz on October 14, 2026, 0.12 percent above the Xetra close of October 13, 2026.

Draufsicht-Arrangement mit Aktienzertifikat, Krankenversicherungspolice, Stethoskop und Medikamentenfläschchen — Cigna Group Flatlay mit Aktienzertifikat ISIN US1255231003, Stethoskop, Versicherungspolice und Medikamentenfläschchen auf weißem Untergrund, Illustration mit AI erstellt.

Cigna raised its full-year 2026 adjusted earnings per share outlook to at least USD 30.45 in the second-quarter review dated July 30, 2026, according to Yahoo Finance. Cigna Group stock was at EUR 253.00 at Lang & Schwarz on October 14, 2026 at 10:39 a.m. CEST, 6.37 percent below its euro 52-week high of EUR 270.20.

Three milestones shape the story

For the fiscal year ended December 31, 2025, Cigna reported revenue of USD 274.9 billion, up 11.2 percent from fiscal 2024, according to GreekSoup.

On July 30, 2026, the second-quarter review showed total revenue of USD 71.7 billion and adjusted earnings per share of USD 7.78. The company also raised its full-year adjusted earnings per share outlook to at least USD 30.45, while second-quarter revenue grew 6.00 percent year over year, according to Yahoo Finance.

On September 30, 2026, The Cigna Group hosted the Investor Day announced in a company release carried by Trivano. The date marked the latest scheduled corporate milestone in the recent company timeline.

The next reporting date

Eulerpool lists November 3, 2026 as the next reporting date. That calendar point gives the raised earnings outlook a clear near-term test, while the second-quarter figures show revenue growth and adjusted earnings per share moving in the same reporting period.

What does the guidance imply?

The second-quarter adjusted earnings per share of USD 7.78 and the full-year floor of USD 30.45 frame the outlook around execution rather than a single quarter. Segment figures add detail: Evernorth revenue grew 6.00 percent year over year to USD 61.5 billion, while Cigna Healthcare revenue grew 10.00 percent to USD 11.8 billion in the second quarter of 2026, according to Yahoo Finance.

Stock remains below its high

At Lang & Schwarz, Cigna Group stock stood at EUR 253.00 in trading on October 14, 2026 at 10:39 a.m. CEST, up 0.12 percent versus the Xetra close of October 13, 2026 at EUR 252.70. The euro 52-week range was EUR 208.40 to EUR 270.20, placing the current quote 6.37 percent below the high. The further course of trading is shown by the continuously updated real-time quote of Cigna Group stock.